Poster

This poster, presented during the IX International Conference on NPS (24 to 26 Oct 2022, Panama), showcases some of the work of the EU Early Warning System on new psychoactive substances. Operated...

Take a journey through some of the key events over the last 25 years of monitoring new psychoactive substances in Europe.

This poster, prepared for the 2019 Lisbon Addictions conference (23-25 October 2019) and highlights some of the most recent research, data and anlysis on drug users in prison.

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the...

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

Take a journey through some of the key moments in the EMCDDA’s first quarter of a century by following the timeline and checking our main milestones.

People who inject drugs (PWID) remain a key risk group for hepatitis C virus infection (HCV) with national prevalence estimates ranging from 13.8% (Malta) to 84.3% (Portugal) in Europe. To reach the...

In the 31 EU/EEA countries, more than 590 000 persons are held in a custodial facility on any given day. According to recent reviews of prison studies from EU countries, prison prevalence...

Partnership is a guiding principle for the EMCDDA as it works to increase its understanding of the external dimension of the drug phenomenon and its implications for public health and security in...

This poster was presented during the WHO Conference on Prison Health, 11-12 December 2017, Lisbon, Portugal. It presents current available data on prevalence of drug use and expert ratings on the availability...